US to pull out from Paris Agreement that limits global warming
The US, the world’s second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.
Climate
Health
Medical
Health
Medical
Pharma
US to withdraw from WHO after an executive order from Donald Trump
The US, the World Health Organization’s top donor, has decided to withdraw from the global health body, accusing it of “mishandling” the Covid-19.
Drugs
Health
Pharma
Vertex, China’s Zai to develop, commercialise kidney disease drug
US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which.
Drugs
Health
Medical
China approves Merck’s human papillomavirus jab for use in males
China has approved Merck & Co.’s human papillomavirus vaccine for males between nine and 26 years amid a fall in sales for the.
Health
Medical
Pharma
China to make humanoid robots, brain-computer interfaces for elderly
China will develop humanoid robots for elderly care and support scientific and technological projects related to senior citizens, according to a state-run news.
Drugs
Health
Medical
Respiratory infections in China have no ‘unusual outbreak patterns’
A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World.
Drugs
Medical
Pharma
WuXi Biologics sells global rights to cancer antibody to Candid for $925m
China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight.
Drugs
Medical
Pharma
EU greenlights AstraZeneca’s non-small cell lung cancer drug
The European Union regulators have greenlighted AstraZeneca’s drug to treat an advanced form of non-small cell lung cancer after it reduced the death.
Drugs
Health
Pharma
Global diabetic population rose fourfold to 828 million in 2022
The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.
Pharma
Pfizer to invest $1b in China over five years, strengthens biotech footprint
HQ Times November 8, 2024: Pfizer under activist investor pressure is busy turning its performance around and has decided to expand its presence.